Skip to content
CIFAR header logo
fr
menu_mobile_logo_alt
  • Our Impact
    • Why CIFAR?
    • Impact Clusters
    • News
    • CIFAR Strategy
    • Nurturing a Resilient Earth
    • AI Impact
    • Donor Impact
    • CIFAR 40
  • Events
    • Public Events
    • Invitation-only Meetings
  • Programs
    • Research Programs
    • Pan-Canadian AI Strategy
    • Next Generation Initiatives
  • People
    • Fellows & Advisors
    • CIFAR Azrieli Global Scholars
    • Canada CIFAR AI Chairs
    • AI Strategy Leadership
    • Solution Network Members
    • Leadership
    • Staff Directory
  • Support Us
  • About
    • Our Story
    • Awards
    • Partnerships
    • Publications & Reports
    • Careers
    • Equity, Diversity & Inclusion
    • Statement on Institutional Neutrality
    • Research Security
  • fr
Health & Well-being

New understanding of how G protein-coupled receptors work allows for more targeted development of drugs

By: CIFAR
1 May, 2018
May 1, 2018
HEALTH-RGB-300-ORANGE

FOCUS OF STUDY

This study identified the first structure of a Glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) G protein complex using cryo-electron microscopy (cryo-EM). Understanding how these receptors bind to and transmit signals from peptide hormones has important implications for treatment of type 2 diabetes and obesity.

BACKGROUND

GPCRs are the largest family of signalling receptors in the human genome. Embedded in a cell’s membrane, they conduct the majority of cellular responses to hormones and neurotransmitters, and outside stimuli like light, odours and taste. They are able to distinguish a wide range of molecules or ligands, and then trigger appropriate cellular responses. Implicated in many diseases, these receptors are key targets for drug discovery efforts. Many drugs that influence GPCR function are already on the market.

Current understanding of the structure and signalling/activation mechanisms of GCPRs is limited due to the challenge of obtaining detailed images. The size and fragility of GCPR complexes make them difficult to crystallize using biological techniques such as x-ray crystallography.

The pioneering work on GPCRs by Brian Kobilka (a collaborator on this study and an advisor in CIFAR’s Molecular Architecture of Life program) and Robert Lefkowitz has been key to understanding the complex network of signalling between cells and organs and the environment. The two scientists received the Nobel Prize in Chemistry in 2012.

Cryo-EM microscopy has recently emerged as a cutting-edge imaging technology for determining structures of macromolecular complexes without having to crystallize the proteins. With cryo-EM, protein molecules are preserved in near-native conditions by rapidly freezing them and imaging them with electrons as single molecules in a thin film of solution. The freezing preserves the structural flexibility of the proteins, which are not forced into orderly arrangements of crystals. This has resulted in new information about processes in the cell that were previously impossible to characterize. Cryo-EM is able to capture 3-D images at near atomic resolution.

Using cryo-EM, this study aims to describe for the first time how glucagon-like peptide-1 (GLP-1), a hormone that plays a key role in regulating insulin secretion, carbohydrate metabolism and appetite, binds to its receptor GLP-1R. GLP-1R belongs to the class B GPCR family and signals mainly through the stimulatory G protein Gs.

STUDY DESIGN AND METHODS

The study involved cryo-EM structure determination, GLP-1 recognition by GLP-1R, comparison with inactive family B receptors, interactions between activated GLP-1R and Gs, and comparison with activated class A GPRCs.

The researchers used rabbit GLP-1R, which shares 92 per cent identity with the human receptor, and formed the complex between receptor and purified Gs in insect cell membranes. They extracted the complex with MNG and purified it by antibody affinity and size-exclusion chromatography.

Using the cryo-EM density map the researchers built and refined a near-atomic resolution structure of the GLP-1–GLP-1R– Gs complex. They used a Titan Krios electron microscope (FEI) at a nominal magnification of 29,000× using a K2 Summit direct electron detector in counting mode. In total, 17,332 images were recorded with the total exposure time set to 10 seconds with intermediate frames recorded every 0.2 seconds.

The resulting cryo-EM density map has been deposited in the Electron Microscopy Data Bank and the coordinates have been deposited in the Protein Data Bank.

KEY FINDINGS

This study successfully captured, for the first time, the cryo-electron microscopy structure of an unmodified GLP-1R in complex with its endogenous peptide ligand, GLP-1, and the heterotrimeric G protein at near-atomic resolution.

It revealed how the hormone binds to its receptor on the outside of a cell, and how this drives changes to the organization of the part that extends into the cell. These changes, in turn, engage and activate the G protein. As the researchers observed, “The peptide is clasped between the N-terminal domain and the transmembrane core of the receptor, and further stabilized by extracellular loops. Conformational changes in the transmembrane domain result in a sharp kink in the middle of transmembrane helix 6, which pivots its intracellular half outward to accommodate the α5-helix of the Ras-like domain of Gs.”

CONCLUSION AND IMPLICATIONS

The near-atomic resolution of the images generated by this study provide a structural framework for understanding the activation of class B GPCRs through hormone binding. Further work is needed to provide a detailed picture of activation pathways in different GPCR classes. However, this study confirms that rapidly evolving cryo-EM technologies have the potential to transform structural studies of these challenging proteins that are important targets for drug discovery efforts.

The insights gained about the signalling and activation mechanisms of the GLP-1 receptor in particular will inform development of drugs for Type 2 diabetes and obesity — resulting in more effective drugs with fewer side effects.


REFERENCE
Yan Zhang, Bingfa Sun, Dan Feng, Hongli Hu, Matthew Chu, Qianhui Qu, Jeffrey T. Tarrasch, Shane Li, Tong Sun Kobilka, Brian K. Kobilka, Georgios Skiniotis. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein. Nature, 2017; DOI: 10.1038/nature22394

Prepared by Clare Walker

  • Follow Us

Related Articles

  • New program provides expert AI advice for policymakers
    April 30, 2025
  • Strengthening Canada’s AI talent ecosystem
    April 16, 2025
  • Humans & the Microbiome: Educational Modules for Public Health Professionals
    April 10, 2025
  • The value of community engagement in AI deployment
    March 31, 2025

Support Us

The Canadian Institute for Advanced Research (CIFAR) is a globally influential research organization proudly based in Canada. We mobilize the world’s most brilliant people across disciplines and at all career stages to advance transformative knowledge and solve humanity’s biggest problems, together. We are supported by the governments of Canada, Alberta and Québec, as well as Canadian and international foundations, individuals, corporations and partner organizations.

Donate Now
CIFAR footer logo

MaRS Centre, West Tower
661 University Ave., Suite 505
Toronto, ON M5G 1M1 Canada

Contact Us
Media
Careers
Accessibility Policies
Supporters
Financial Reports
Subscribe

  • © Copyright 2025 CIFAR. All Rights Reserved.
  • Charitable Registration Number: 11921 9251 RR0001
  • Terms of Use
  • Privacy
  • Sitemap

Subscribe

Stay up to date on news & ideas from CIFAR.

Fields marked with an * are required

Je préfère m’inscrire en français (cliquez ici).


Subscribe to our CIFAR newsletters: *

You can unsubscribe from these communications at any time. View our privacy policy.


As a subscriber you will also receive a digital copy of REACH, our annual magazine which highlights our researchers and their breakthroughs with long-form features, interviews and illustrations.


Please provide additional information if you would like to receive a print edition of REACH.


This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.
Accept Learn more

Notifications